Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
AffiliationDepartments of Endocrinology and Radiotherapy, Christie Hospital and Holt Radium Institute, Manchester
MetadataShow full item record
AbstractWe have studied a women who presented at the age of 51 with a large FSH and alpha-subunit producing pituitary adenoma. Following insertion of ventriculo-peritoneal shunts and external pituitary irradiation there was no change in the elevated serum concentrations of FSH, and alpha-subunit over a four year period although she developed both ACTH and TSH deficiency. Various drugs, however, did alter the FSH and alpha-subunit concentrations and these changes suggest possible mechanisms controlling FSH secretion. Ethinyloestradiol 0.03 mg daily for three weeks suppressed serum FSH to 77% of the basal level (240 +/- 35 i.u./l to 184 +/- 20 i.u./l) but alpha-subunit rose to 130% of basal level (281 +/- 50 ng/ml to 366 +/- 40 ng/ml). On ethinyloestradiol 0.1 mg daily, FSH suppressed to 17% of basal (40 +/- 11 i.u./l) with no change in alpha-subunit concentration, while on 0.2 mg daily suppression of FSH was similar but alpha-subunit fell to 59% of basal (190 +/- 28 ng/ml). Dexamethasone, 3 mg daily for one week reduced FSH to 53% of the initial concentration and alpha-subunit to 74% while bromocriptine 7.5 mg daily for three months, reduced FSH to 39% and alpha-subunit to 66% of basal. Neither thyroxine, 0.2 mg daily for four weeks, nor an LHRH analogue, (Buserelin, Hoechst) 200 micrograms, three times daily for three months elicited any effect. Chromatography on Sephadex G100 showed that serum FSH and alpha-subunit both had Kav values somewhat lower than those of their standard counterparts (FSH, 0.20 vs 0.25; alpha-subunit 0.35 vs 0.45).(ABSTRACT TRUNCATED AT 250 WORDS)
CitationDiscordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour. 1984, 21 (2):123-9 Clin Endocrinol
- Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone.
- Authors: Surmont DW, Winslow CL, Loizou M, White MC, Adams EF, Mashiter K
- Issue date: 1983 Sep
- The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
- Authors: Roman SH, Goldstein M, Kourides IA, Comite F, Bardin CW, Krieger DT
- Issue date: 1984 Feb
- Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
- Authors: Damjanović S, Micić D, Popović V, Petakov M, Kendereski A, Sumarac M, Manojlović D, Mićić J
- Issue date: 1991 Apr
- Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine.
- Authors: Vance ML, Ridgway EC, Thorner MO
- Issue date: 1985 Sep
- Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
- Authors: Beck-Peccoz P, Bassetti M, Spada A, Medri G, Arosio M, Giannattasio G, Faglia G
- Issue date: 1985 Sep